Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

ClinicalTrials.gov ID: NCT05018650

Public ClinicalTrials.gov record NCT05018650. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Controlled, Interventional Clinical Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical MonoPoint® Reperfusion System for Aspiration Embolectomy in Acute Ischemic Stroke Patients (SUMMIT MAX)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The SUMMIT MAX study is a prospective, randomized, controlled, interventional clinical trial to evaluate the safety and effectiveness of the Route 92 Medical MonoPoint® Reperfusion System with the Hi Point 88 and HiPoint 70 Reperfusion Catheters for aspiration thrombectomy in acute ischemic stroke patients.

Study identification

NCT ID
NCT05018650
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Route 92 Medical, Inc.
Industry
Enrollment
250 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2021 (Actual)
Primary completion
Feb 19, 2024 (Actual)
Completion
May 22, 2024 (Actual)
Last update posted
Apr 9, 2025

2021 – 2024

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Banner Health Mesa Arizona 85202 —
Mercy San Juan Medical Center Carmichael California 95608 —
Christiana Care Newark Delaware 19718 —
Baptist Jacksonville Jacksonville Florida 32207 —
Baptist Hospital of Miami Miami Florida 33176 —
Advocate Aurora Health Chicago Illinois 60657 —
University of Kansas Kansas City Kansas 66160 —
Baptist Health Lexington Lexington Kentucky 40503 —
Tufts Boston Massachusetts 02111 —
Boston Medical Center Boston Massachusetts 02118 —
University of Massachusetts Worcester Massachusetts 01655 —
Saint Luke's Kansas City Missouri 64111 —
Cooper Health System Camden New Jersey 08103 —
Rutgers Piscataway New Jersey 08854 —
Stony Brook University Hospital Stony Brook New York 11794 —
Cleveland Clinic Cleveland Ohio 44195 —
Ohio Health Columbus Ohio 43214 —
Wright State University Dayton Ohio 45409 —
Mercy Health St. Vincent Toledo Ohio 43608 —
OHSU Portland Oregon 97219 —
Geisinger Clinic Danville Pennsylvania 17822 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
UPMC Pittsburgh Pennsylvania 15213 —
Fort Sanders Medical Center Knoxville Tennessee 37902 —
University of Texas Southwestern Dallas Texas 75390 —
Valley Baptist Harlingen Texas 78550 —
Medical City Plano Plano Texas 75075 —
University of Utah Salt Lake City Utah 84123 —
West Virginia University Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05018650, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2025 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05018650 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →